Literature DB >> 17823315

A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice.

Katsuhiko Tabuchi1, Jacqueline Blundell, Mark R Etherton, Robert E Hammer, Xinran Liu, Craig M Powell, Thomas C Südhof.   

Abstract

Autism spectrum disorders (ASDs) are characterized by impairments in social behaviors that are sometimes coupled to specialized cognitive abilities. A small percentage of ASD patients carry mutations in genes encoding neuroligins, which are postsynaptic cell-adhesion molecules. We introduced one of these mutations into mice: the Arg451-->Cys451 (R451C) substitution in neuroligin-3. R451C mutant mice showed impaired social interactions but enhanced spatial learning abilities. Unexpectedly, these behavioral changes were accompanied by an increase in inhibitory synaptic transmission with no apparent effect on excitatory synapses. Deletion of neuroligin-3, in contrast, did not cause such changes, indicating that the R451C substitution represents a gain-of-function mutation. These data suggest that increased inhibitory synaptic transmission may contribute to human ASDs and that the R451C knockin mice may be a useful model for studying autism-related behaviors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823315      PMCID: PMC3235367          DOI: 10.1126/science.1146221

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  35 in total

1.  Disorder-associated mutations lead to functional inactivation of neuroligins.

Authors:  Ben Chih; Shehla Khan Afridi; Lorraine Clark; Peter Scheiffele
Journal:  Hum Mol Genet       Date:  2004-05-18       Impact factor: 6.150

Review 2.  Neuronal oscillations in cortical networks.

Authors:  György Buzsáki; Andreas Draguhn
Journal:  Science       Date:  2004-06-25       Impact factor: 47.728

3.  A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin.

Authors:  Oliver Prange; Tak Pan Wong; Kimberly Gerrow; Yu Tian Wang; Alaa El-Husseini
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-09       Impact factor: 11.205

4.  Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins.

Authors:  Ethan R Graf; XueZhao Zhang; Shan-Xue Jin; Michael W Linhoff; Ann Marie Craig
Journal:  Cell       Date:  2004-12-29       Impact factor: 41.582

5.  Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin.

Authors:  Y A Ushkaryov; A G Petrenko; M Geppert; T C Südhof
Journal:  Science       Date:  1992-07-03       Impact factor: 47.728

6.  The memory structure of autistic idiot-savant mnemonists.

Authors:  N O'Connor; B Hermelin
Journal:  Br J Psychol       Date:  1989-02

7.  Structures, alternative splicing, and neurexin binding of multiple neuroligins.

Authors:  K Ichtchenko; T Nguyen; T C Südhof
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

8.  Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses.

Authors:  J Y Song; K Ichtchenko; T C Südhof; N Brose
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

9.  Neuroligin 1: a splice site-specific ligand for beta-neurexins.

Authors:  K Ichtchenko; Y Hata; T Nguyen; B Ullrich; M Missler; C Moomaw; T C Südhof
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

10.  Neuroligin 2 is exclusively localized to inhibitory synapses.

Authors:  Frédérique Varoqueaux; Stéphane Jamain; Nils Brose
Journal:  Eur J Cell Biol       Date:  2004-09       Impact factor: 4.492

View more
  415 in total

1.  PICK1 mediates synaptic recruitment of AMPA receptors at neurexin-induced postsynaptic sites.

Authors:  Junyu Xu; Chuen Kam; Jian-Hong Luo; Jun Xia
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 2.  Processing of cholinesterase-like α/β-hydrolase fold proteins: alterations associated with congenital disorders.

Authors:  Antonella De Jaco; Davide Comoletti; Noga Dubi; Shelley Camp; Palmer Taylor
Journal:  Protein Pept Lett       Date:  2012-02       Impact factor: 1.890

Review 3.  The contribution of GABAergic dysfunction to neurodevelopmental disorders.

Authors:  Kartik Ramamoorthi; Yingxi Lin
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

4.  Selective impact of MeCP2 and associated histone deacetylases on the dynamics of evoked excitatory neurotransmission.

Authors:  Erika D Nelson; Manjot Bal; Ege T Kavalali; Lisa M Monteggia
Journal:  J Neurophysiol       Date:  2011-04-20       Impact factor: 2.714

Review 5.  CNVs: harbingers of a rare variant revolution in psychiatric genetics.

Authors:  Dheeraj Malhotra; Jonathan Sebat
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 6.  Annual Research Review: Development of the cerebral cortex: implications for neurodevelopmental disorders.

Authors:  John L R Rubenstein
Journal:  J Child Psychol Psychiatry       Date:  2010-08-24       Impact factor: 8.982

7.  Structural insights into the exquisite selectivity of neurexin/neuroligin synaptic interactions.

Authors:  Philippe Leone; Davide Comoletti; Géraldine Ferracci; Sandrine Conrod; Simon U Garcia; Palmer Taylor; Yves Bourne; Pascale Marchot
Journal:  EMBO J       Date:  2010-06-11       Impact factor: 11.598

8.  Congenital hypothyroidism mutations affect common folding and trafficking in the α/β-hydrolase fold proteins.

Authors:  Antonella De Jaco; Noga Dubi; Shelley Camp; Palmer Taylor
Journal:  FEBS J       Date:  2012-11-01       Impact factor: 5.542

Review 9.  Activity-dependent neuronal signalling and autism spectrum disorder.

Authors:  Daniel H Ebert; Michael E Greenberg
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

10.  Impaired hippocampal neuroligin-2 function by chronic stress or synthetic peptide treatment is linked to social deficits and increased aggression.

Authors:  Michael A van der Kooij; Martina Fantin; Igor Kraev; Irina Korshunova; Jocelyn Grosse; Olivia Zanoletti; Ramon Guirado; Clara Garcia-Mompó; Juan Nacher; Michael G Stewart; Vladimir Berezin; Carmen Sandi
Journal:  Neuropsychopharmacology       Date:  2013-11-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.